Sofia D Merajver

Title: Sofia D Merajver: Innovator in Anti-Angiogenic Therapies

Introduction

Sofia D Merajver is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of anti-angiogenic therapies, focusing on innovative compounds that can aid in the treatment of various diseases, including cancer. With a total of 3 patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

One of her latest patents is titled "Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies." This invention discloses copper-binding compounds with improved properties and methods for their use in preventing and treating angiogenic diseases, such as cancer. The advantages of this invention include enhanced stability of the compounds without a reduction in efficacy. Additionally, pharmaceutical compositions, therapeutic kits, and combination treatment methods are provided. Another significant patent involves "Methods and compositions for the treatment of angiogenic diseases," which presents agents that can bind to copper and form a tripartite complex with proteins. These agents are utilized in the prevention and treatment of diseases with a vascular component, including solid tumors.

Career Highlights

Sofia D Merajver is affiliated with the University of Michigan, where she continues her research and development in the field of anti-angiogenic therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Some of her notable coworkers include George J Brewer and Dimitri Coucouvanis, who have collaborated with her on various research projects and patents.

Conclusion

Sofia D Merajver is a trailblazer in the field of anti-angiogenic therapies, with her innovative patents contributing to the fight against cancer and other angiogenic diseases. Her work exemplifies the impact of scientific research on healthcare advancements.